Sanitas's Strategic Investment in MIMO Biosciences to Boost Oncology Research
Deal News | Dec 11, 2024 | Iberian Lawyer
Gómez-Acebo & Pombo has facilitated a significant transaction in the healthcare sector by advising Sanitas on its investment in MIMO Biosciences. MIMO Biosciences, a spin-off from the University of Navarra's CIMA, specializes in cancer immunotherapy. The collaboration positions Sanitas, a prominent healthcare company, alongside two private investors to enter as a shareholder in MIMO Biosciences. This partnership is centered around a framework agreement for health research, particularly aiming to advance the development of immunotherapy drugs for hematological cancers such as multiple myeloma and lymphomas. This investment underscores Sanitas's commitment to driving innovation in preclinical research services, focusing on modeling genetic alterations in various hematological malignancies. The legal expertise provided by Gómez-Acebo & Pombo involved a multi-disciplinary team covering corporate, public, regulated sectors, tax, intellectual property, and labor and employment law, ensuring a comprehensive advisory service for the transaction.
Sectors
- Healthcare
- Biotechnology
- Legal Advisory
Geography
- Spain – The article is centered around Spanish entities: Sanitas, MIMO Biosciences, and the CIMA University of Navarra, as well as the involvement of the Spanish law firm Gómez-Acebo & Pombo.
Industry
- Healthcare – The article involves the healthcare industry as Sanitas is a healthcare company investing in a project related to health research and cancer immunotherapy.
- Biotechnology – Relevant because MIMO Biosciences is a biotechnology spin-off from CIMA University of Navarra focusing on cancer immunotherapy research.
- Legal Advisory – Gómez-Acebo & Pombo's role as legal advisors in the transaction highlights their importance in facilitating the investment deal.
Financials
- Not disclosed – The financial terms of Sanitas's investment in MIMO Biosciences are not disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Sanitas | Investor | Company | A healthcare company making a strategic investment in MIMO Biosciences to enhance its research and development capabilities. |
| MIMO Biosciences | Target | Company | A biotechnology spin-off from CIMA University of Navarra focusing on cancer immunotherapy. |
| Gómez-Acebo & Pombo | Legal Advisor | Company | A law firm providing legal advisory services to Sanitas in its investment in MIMO Biosciences. |
| CIMA University of Navarra | Origin | Company | Research institution where MIMO Biosciences was spun off, contributing significant scientific research in immunotherapy. |